<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04835818</url>
  </required_header>
  <id_info>
    <org_study_id>201901147RIND</org_study_id>
    <nct_id>NCT04835818</nct_id>
  </id_info>
  <brief_title>Point-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia</brief_title>
  <official_title>Clinical Impact on Point-of-Care Multiplex Polymerase Chain Reaction (PCR) Testing for Critically Ill Adult Patients With Community-acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical Impact on Point-of-Care Multiplex PCR Testing for Critically Ill Adult Patients With&#xD;
      Community-acquired Pneumonia - A cluster randomization study in ICU units within one medical&#xD;
      center.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Point-of-Care Multiplex PCR Testing could narrow down the pathogens causing severe&#xD;
      community-acquired pneumonia(CAP). Our hypothesis is that the result of Point-of-Care&#xD;
      Multiplex PCR Testing could help primary physician to reduce antibiotics use.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2019</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intravenous antibiotic-free day within 14 days</measure>
    <time_frame>up to 14 days</time_frame>
    <description>days without intravenous antibiotics within 14 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU stay</measure>
    <time_frame>up to 21 days</time_frame>
    <description>days of stay in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antibiotic-free day within 21 days</measure>
    <time_frame>21 days</time_frame>
    <description>days without antibiotics within 21 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravenous antibiotic-free day within 21 days</measure>
    <time_frame>up to 21 days</time_frame>
    <description>days without intravenous antibiotics within 21 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free day within 28 days</measure>
    <time_frame>up to 28 days</time_frame>
    <description>days without intravenous antibiotics within 28 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Community-acquired Pneumonia</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Reporting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>check point-of-care Multiplex PCR for pneumonia pathogens and report results to primary care physician</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>check point-of-care Multiplex PCR for pneumonia pathogens but do NOT report results to primary care physician. Let primary care physician provide usual standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Provide the panel report to the primary care physician</intervention_name>
    <description>Point-of-care Multiplex PCR Respiratory Panel (BIOFIRE FilmArray) and Pneumonia Panel results (BIOFIRE FilmArray)</description>
    <arm_group_label>Reporting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (age &gt;20 y/o)&#xD;
&#xD;
          -  ICU admission for acute respiratory failure due to community-acquired pneumonia by&#xD;
             clinical diagnosis&#xD;
&#xD;
          -  Treatment with endotracheal Intubation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Aspiration pneumonia (including witnessed aspiration and chronic bedridden status)&#xD;
&#xD;
          -  Nosocomial infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Chung Chuang, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Chung Chuang, MD. PhD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>65045</phone_ext>
    <email>weischuang@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yu-Chung Chuang, MD. PhD</last_name>
    <phone>886-972652532</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Chung Chuang, MD PhD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>65045</phone_ext>
      <email>weischuang@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ying-Chun Chien, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wang-Da Liu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 5, 2021</study_first_submitted>
  <study_first_submitted_qc>April 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Community-acquired Pneumonia</keyword>
  <keyword>Critical Illness</keyword>
  <keyword>Point-of-care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

